The primary target antigenic site in heymann nephritis is the renal proximal convoluted tubules' brush border associated zone of cells

Autoimmune Disorders: Symptoms, Diagnosis and Treatment

Volumn , Issue , 2011, Pages 281-292

  Barabas, Arpad Zsigmond ^a   Cole, Chad Douglas ^b   Weir, Donald Mackay ^c   Lafreniere, Rene ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Heymann nephritis; Immune complex glomerulonephritis; Modified vaccination technique; Nephritogenic antigen

Indexed keywords

EID: 84867051449     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (38)

1. Alousi, MA; Post, RS; Heymann, W. Experimental autoimmune nephrosis in rats. Morphogenesis of the glomerular lesion: immunohistochemical and electron microscopic studies. Am. J. Pathol., 1969, 54, 47-71.
2. Andres, G; Brentjens, JR; Caldwell, PR; Camussi G; Matsuo S. Formation of immune deposits and disease. Lab Invest, 1986, 55, 510-20.
3. Barabas, AZ; Cole, CD; Barabas, AD; Bahlis, NJ; Lafreniere, R. New vaccination technology for endogenous antigen-derived ailments. IDrugs., 2008, 11, 111-5.
4. Barabas, AZ; Cole, CD; Barabas, AD; Bahlis, NJ; Lafreniere, R. A vaccination technique to combat presently untreatable chronic ailments. Bio 4Processing Journal, 2007, 6, 12-8.
5. Barabas, AZ; Cole, CD; Barabas, AD; Barabas, AN; Lafreniere, R. Reduced incidence of slowly progressive Heymann nephritis in rats immunized with a modified vaccination technique. Clin Dev.Immunol, 2006, 13, 17-24.
6. Barabas, AZ; Cole, CD; Barabas, AD; Cowan, JM; Yoon, CS; Waisman, DM; et al. Presence of immunoglobulin M antibodies around the glomerular capillaries and in the mesangium of normal and passive Heymann nephritis rats. Int. J. Exp. Pathol., 2004, 85, 201-12.
7. Barabas, AZ; Cole, CD; Barabas, AD; Graeff, RM; Lafreniere, R; Weir, DM. Correcting autoimmune anomalies in autoimmune disorders by immunological means, employing the modified vaccination technique. Autoimmun Rev, 2009, 8, 552-7.
8. Barabas, AZ; Cole, CD; Barabas, AD; Lafreniere, R. Production of a new model of slowly progressive Heymann nephritis. Int JExp Pathol, 2003, 84, 245-58.
9. Barabas, AZ; Cole, CD; Barabas, AD; Lafreniere, R. Down-regulation of pathogenic autoantibody response in a slowly progressive Heymann nephritis kidney disease model. Int. J. Exp. Pathol., 2004, 85, 321-34.
10. Barabas, AZ; Cole, CD; Barabas, AD; Lafreniere, R. Production of Heymann nephritis by a chemically modified renal antigen. Int. J. Exp. Pathol., 2004, 85, 277-85.
11. Barabas, AZ; Cole, CD; Barabas, AD; Lafreniere, R. Downregulation of a pathogenic autoantibody response by IgM autoantibodies directed against the nephritogenic antigen in slowly progressive Heymann nephritis. Pathol Int, 2006, 56, 181-90.
12. Barabas, AZ; Cole, CD; Barabas, AD; Lafreniere, R. A modified vaccination technique for the prevention and treatment of an experimental autoimmune kidney disease. Ann. N. Y. Acad. Sci., 2007, 1110, 619-29.
13. Barabas, AZ; Cole, CD; Barabas, AD; Lafreniere, R. Preventative and therapeutic vaccination to combat an experimental autoimmune kidney disease. Biologics: Targets & Therapy, 2007, 1, 59-68.
14. Barabas, AZ; Cole, CD; Barabas, AD; Lafreniere, R. An experimental autoimmune kidney disease caused by pathogenic autoantibodies. In Petrelli C, editor. New research on autoantibodies. Hauppauge NY: Nova Science Publishers, Inc, 2008, 151-72.
15. Barabas, AZ; Lafreniere, R. Antigen-specific down-regulation of immunopathological events in an experimental autoimmune kidney disease. Autoimmun Rev, 2005, 4, 56570.
16. Barabas, AZ; Lannigan, R. Auto-immune nephritis in rats. J. Pathol., 1969, 97, 537-43.
17. Barabas, AZ; Weir, DM; Cole, CD; Barabas, AD; Bahlis, NJ; Graeff, RM; et al. Preventing and treating chronic disorders using the modified vaccination technique. Front Biosci., 2009, 14, 3892-8.
18. Becker, H; Weber, C; Storch, S; Federlin, K. Relationship between CD5+ B lymphocytes and the activity of systemic autoimmunity. Clin Immunol Immunopathol., 1990, 56, 219-25.
19. Calvert, JE; Duggan-Keen, MF; Smith, SW; Givan, AL; Bird, P. The CD5+ B cell: a B cell lineage with a central role in autoimmune disease? Autoimmunity, 1988, 1, 223-40.
20. Casali, P; Notkins, AL. CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire. Immunol.Today, 1989, 10, 364-8.
21. Ebringer, A. Molecular mimicry as the basis of a new theory of autoimmunity. In Zouali M, editor. Frontiers in Autoimmunity: fundamental aspects and clinical perspectives. Amsterdam Netherlands: IOS Press; 2003, 79-99.
22. Ebringer, A; Thorpe, C; Pirt, J; Wilson, C; Cunningham, P; Ettelaie, C. Bovine spongiform encephalopathy: is it an autoimmune disease due to bacteria showing molecular mimicry with brain antigens? Environ.Health Perspect., 1997, 105, 1172-4.
23. Edgington, TS; Glassock, RJ; Watson, JI; Dixon, FJ. Characterization and isolation of specific renal tubular epithelial antigens. J. Immunol., 1967, 99, 1199-210.
24. Elson, CJ; Weir, DM. Chemotaxis of polymorphs induced by tissue antigens and normal serum in rats: a possible clearance mechanism. Clin Exp Immunol, 1967, 2, 5818.
25. Glassock, RJ; Edgington, TS; Watson, JI; Dixon, FJ. Autologous immune complex nephritis induced with renal tubular antigen. II. The pathogenetic mechanism. J. Exp. Med., 1968, 127, 573-88.
26. Hayakawa, K; Hardy, RR; Parks, DR; Herzenberg, LA. The "Ly-1 B" cell subpopulation in normal immunodefective, and autoimmune mice. J. Exp. Med., 1983, 157, 202-18.
27. Heymann, W; Hackel, DB; Harwood, S; Wilson, SG; Hunter, JLP. Production of the nephritic syndrome in rat by Freund's adjuvant and rat kidney suspension. Proc. Soc. Exp. Biol. Med., 1959, 100, 660-4.
28. Kasaian, MT; Casali, P. Autoimmunity-prone B-1 (CD5 B) cells, natural antibodies and self recognition. Autoimmunity, 1993, 15, 315-29.
29. Kerjaschki, D; Farquhar, MG. Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats. J. Exp. Med, 1983, 157, 667-86.
30. Mendrick, DL; Noble, B; Brentjens, JR; Andres, GA. Antibody-mediated injury to proximal tubules in Heymann nephritis. Kidney Int., 1980, 18, 328-43.
31. Nawata, Y; Stall, AM; Herzenberg, LA; Eugui, EM; Allison, AC. Surface immunoglobulin ligands and cytokines differentially affect proliferation and antibody production by human CD5+ and CD5-B lymphocytes. Int Immunol, 1990, 2, 603-14.
32. Raychowdhury, R; Zheng, G; Brown, D; McCluskey, RT. Induction of Heymann nephritis with a gp330/megalin fusion protein. Am. J. Pathol., 1996, 148, 1613-23.
33. Solvason, N; Chen, X; Shu, F; Kearney, JF. The fetal omentum in mice and humans. A site enriched for precursors of CD5 B cells early in development. Ann. N. Y. Acad. Sci., 1992, 651, 10-20.
34. Weir, DM. The immunologicial consequences of cell death. Lancet, 1967, 2, 1071-3.
35. Weir, DM; Elson, CJ. Antitissue antibodies and immunological tolerance to self. Arthritis Rheum., 1969, 12, 254-60.
36. Weir, DM; Pinckard, RN. Failure to induce tolerance to rat tissue antigens. Immunology, 1967, 13, 373-80.
37. Weir, DM; Pinckard, RN; Elson, CJ; Suckling, DE. Naturally occurring anti-tissue antibodies in rat sera. Clin.Exp.Immunol., 1966, 1, 433-42.
38. Wucherpfennig, KW. Mechanisms for the induction of autoimmunity by infectious agents. J.Clin.Invest, 2001, 108, 1097-104.